This infographic illustrates the key achievements of the project to establish and validate a manufacturing process to produce semisynthetic artemisinin (ssART) at industrial scale and commercialize ssART. Production of ssART aims to supplement a historically volatile botanical supply chain, strengthening the artemisinin market and ensuring that the global need for artemisinin-based combination therapies can be met, thus supporting current worldwide malaria control measures and strategies for malaria elimination.
Corporate author(s): PATH
Publication date: April 2016
304 KB PDF
Hard copies are not available.
Some digital files may be saved at low resolutions to conserve file size. Versions with higher quality may be available; see the contact information below to enquire.
Related regions: Global
- Emerging and epidemic diseases > Malaria
- For advocates and policymakers > Health technologies
- For advocates and policymakers > Public-private partnerships
For more information…
Contact: PATH Publications
Mailing address: PATH, PO Box 900922, Seattle, WA 98109 USA